Open an account

Biodexa Pharmaceuticals

BDRX · NASDAQ

$0.4233+$0.0093 (+2.25%)TodayMarket closed ·
Prev close $0.414

About BDRX

Biodexa Pharmaceuticals Plc is a drug delivery technology company. The company is headquartered in Abingdon, Oxfordshire and currently employs 11 full-time employees. The company went IPO on 2014-12-08. The firm is developing a pipeline of products for the treatment of diseases with unmet medical needs. The Company’s lead development program, eRapa, is under development for familial adenomatous polyposis and non-muscle invasive bladder cancer; tolimidone, under development as a for the treatment of type 1 diabetes; and MTX110, which is being studied in aggressive rare/orphan brain cancer indications, including recurrent glioblastoma, diffuse midline glioma, or DMG, and medulloblastoma. Its technologies include Q-Sphera, MidaCore and MidaSolve. The Q-Sphera platform is a polymer microsphere microtechnology used for sustained delivery to prolong and control the release of therapeutics over an extended period of time, from weeks to months. Its MidaSolve platform is an oligosaccharide nanotechnology that is used to solubilize drugs so that they can be administered in liquid form directly and locally into tumors.

Employees
11
Headquarters
Abingdon, Oxfordshire
Listed
Dec 8, 2014
Sector
Health Care
Industry
Biotechnology
Website
biodexapharma.com

BDRX key statistics

Market cap
426.03K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
3.82M
Volume
240.60K
Open price
$0.3845
High today
$0.43
Low today
$0.3845
52 Week high
$44.70
52 Week low
$0.3371

Biodexa Pharmaceuticals (BDRX) at a glance

As of Oct 23, 2026, Biodexa Pharmaceuticals (BDRX) shares are priced at $0.4233, giving the company a market cap of 426.03K and a price-to-earnings ratio of 0.00.

Today the stock has traded between $0.3845 and $0.43. The current price is 10.1% above the day's low and 1.6% below its high.

Volume so far is 240.60K shares, below the average of 3.82M shares a day.

Over the past year Biodexa Pharmaceuticals has ranged from $0.3371 to $44.70, and now sits 0% of the way up that range.

BDRX news

  • Press releaseACCESS Newswire

    The Longview: Fireside Chat with Biodexa CEO Stephen Stamp

  • 12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • 12 Health Care Stocks Moving In Wednesday's Intraday Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Thursday's After-Market Session

  • 12 Health Care Stocks Moving In Wednesday's After-Market Session

  • 12 Health Care Stocks Moving In Tuesday's Pre-Market Session

  • Press releaseACCESS Newswire

    Biodexa Licenses Phase 1 Ready Drug Candidate from Otsuka for Rare Stomach Cancer

Similar companies

Companies in the same industry as Biodexa Pharmaceuticals

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.